University Hospital Ostrava
Welcome,         Profile    Billing    Logout  
 17 Trials 
32 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cibula, David
innovaTV 301, NCT04697628 / 2019-001655-39: Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer

Active, not recruiting
3
502
Europe, Canada, Japan, US, RoW
tisotumab vedotin, TIVDAK, topotecan, vinorelbine, gemcitabine, irinotecan, pemetrexed
Seagen Inc., Genmab
Cervical Cancer
07/23
08/25
PORTEC-4a, NCT03469674: Molecular Profile-based Versus Standard Adjuvant Radiotherapy in Endometrial Cancer

Active, not recruiting
3
550
Europe, RoW
Vaginal brachytherapy, External beam radiotherapy, Observation
Leiden University Medical Center, Dutch Cancer Society, Comprehensive Cancer Centre The Netherlands
Endometrial Cancer Stage I, Endometrial Cancer Stage II
12/24
12/28
ENGOT-EN20, NCT05611931 / 2022-002540-42: Selinexor in Maintenance Therapy After Systemic Therapy for Participants with P53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma

Jul 2024 - Dec 2024: Top-line data from XPORT-EC trial in participants with TP53 wild type endometrial cancer
Recruiting
3
220
Europe, Canada, US, RoW
Selinexor, KPT-330, Matching Placebo for selinexor
Karyopharm Therapeutics Inc, GOG Foundation, European Network of Gynaecological Oncological Trial Groups (ENGOT), Belgium and Luxembourg Gynaecological Oncology Group, North Eastern German Society of Gynaecological Oncology, Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies, Spanish Research Group in Ovarian Cancer, The Central and Eastern European Gynecologic Oncology Group, Israeli Society of Gynecologic Oncology, Australia New Zealand Gynaecological Oncology Group
Endometrial Cancer
01/25
01/28
PHOCUS, NCT04789694: Prehabilitation in Gynaecological Cancer Patients

Recruiting
3
64
RoW
Physiological intervention, Psychological intervention, Nutritional intervention
Charles University, Czech Republic, University Hospital Ostrava, University Hospital Olomouc, University Hospital Pilsen, The Faculty Hospital Na Bulovce
Ovarian Cancer, Ovarian Cancer Stage III, Ovarian Cancer Stage IV, Endometrial Cancer, Frailty
06/25
06/26
FLORA-4, NCT04498117 / 2020-002270-26: Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery

Active, not recruiting
3
615
Europe, Canada, US, RoW
Oregovomab, MAb-B43.13, Paclitaxel, Taxol, Carboplatin, Paraplatin, Placebo
CanariaBio Inc., Gynecologic Oncology Group, Iqvia Pty Ltd
Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Ovarian Cancer, Ovarian Serous Adenocarcinoma, Fallopian Tube Neoplasms, Fallopian Tube Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma, Peritoneal Cancer, Peritoneal Carcinoma, Peritoneal Neoplasms
09/25
08/27
CERVANTES, NCT04989647: Intermediate Risk Cervical Cancer: Radical Surgery +/- Adjuvant Radiotherapy

Recruiting
3
514
RoW
No adjuvant therapy, Adjuvant radiotherapy
The Central and Eastern European Gynecologic Oncology Group
Cervical Cancer
12/29
12/32
SENTIX, NCT02494063: Sentinel Lymph Node Biopsy in Patients With Early Stages Cervical Cancer

Completed
N/A
600
RoW
Sentinel lymph node biopsy, At least unilateral systematic pelvic lymph node dissection
Charles University, Czech Republic
Cervical Cancer
12/22
02/24
TESLA-1, NCT04665544: Tracers for Endometrial Cancer Sentinel Node Labeling

Recruiting
N/A
83
Europe, RoW
SLN side-specific detection rate using radioactive tracer with/without blue dye and ICG tracer.
University Medical Centre Maribor
Endometrial Cancer, Sentinel Lymph Node
01/23
01/24
SENTICOL III, NCT03386734: International Validation Study of Sentinel Node Biopsy in Early Cervical Cancer

Active, not recruiting
N/A
989
Europe, Canada, Japan, RoW
SLN biopsy only, SLN biopsy + PLN dissection
Centre Hospitalier Universitaire de Besancon, ARCAGY/ GINECO GROUP, European Network of Gynaecological Oncological Trial Groups (ENGOT)
Cervical Cancer
05/27
05/29
Ďuraš, Juraj
CLSGMCLPOLA, NCT04913103: Study of PV in Combination With Bendamustine and Rituximab for Patients With R/R MCL

Not yet recruiting
2
21
RoW
Polatuzumab vedotin, Polivy, Bendamustine Hydrochloride, Bendamustine Accord, Bendamustine Glenmark, Bendamustine KABI, Rituximab, Mabthera, Rixathon, Truxima
Czech Lymphoma Study Group
Lymphoma, Mantle-Cell
08/26
08/27
Roubec, Martin
EMIAS, NCT05153642: Emergent Microsurgical Intervention in Acute Stroke Patients After Mechanical Thrombectomy Failure Trial

Recruiting
N/A
50
RoW
Microsurgical intervention
University Hospital Ostrava, České Budějovice Hospital
Acute Stroke, Surgical Procedure
12/22
12/22
Tension, NCT03094715: Efficacy and Safety of Thrombectomy in Stroke With Extended Lesion and Extended Time Window

Terminated
N/A
253
Europe, Canada, RoW
Thrombectomy, Mechanical thrombectomy, Best medical care, Control group
University Hospital Heidelberg, Karolinska University Hospital, Eppdata GmbH Hamburg, Germany, Aarhus University Hospital, Medical University Innsbruck, Groupe Hospitalier Pitie-Salpetriere, Oslo University Hospital, University Hospital, Martin, Charles University, Czech Republic, Hospices Civils de Lyon, CHU de Reims, Epidemiological and Clinical Research Information Network, STROKE ALLIANCE FOR EUROPE, International Consortium for Health Outcome Measurement, Inc., Europan Society for Minimally Invasive Neurological Therapy, Universitätsklinikum Hamburg-Eppendorf
Stroke, Acute, Cerebral Stroke, Cerebrovascular Stroke, Apoplexy; Brain
05/23
11/23
NCT04910217: Robot-Assisted Gait Therapy in the Subacute Phase of First Ischemic Stroke

Recruiting
N/A
80
RoW
Conventional rehabilitation, Leg/lower body exerciser device intervention., Lokomat intervention
University Hospital Ostrava, Masaryk University, VSB - Technical University of Ostrava
Ischemic Stroke
12/25
12/25
Klat, Jaroslav
ENGOT-EN20, NCT05611931 / 2022-002540-42: Selinexor in Maintenance Therapy After Systemic Therapy for Participants with P53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma

Jul 2024 - Dec 2024: Top-line data from XPORT-EC trial in participants with TP53 wild type endometrial cancer
Recruiting
3
220
Europe, Canada, US, RoW
Selinexor, KPT-330, Matching Placebo for selinexor
Karyopharm Therapeutics Inc, GOG Foundation, European Network of Gynaecological Oncological Trial Groups (ENGOT), Belgium and Luxembourg Gynaecological Oncology Group, North Eastern German Society of Gynaecological Oncology, Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies, Spanish Research Group in Ovarian Cancer, The Central and Eastern European Gynecologic Oncology Group, Israeli Society of Gynecologic Oncology, Australia New Zealand Gynaecological Oncology Group
Endometrial Cancer
01/25
01/28
TESLA-1, NCT04665544: Tracers for Endometrial Cancer Sentinel Node Labeling

Recruiting
N/A
83
Europe, RoW
SLN side-specific detection rate using radioactive tracer with/without blue dye and ICG tracer.
University Medical Centre Maribor
Endometrial Cancer, Sentinel Lymph Node
01/23
01/24
SENTICOL III, NCT03386734: International Validation Study of Sentinel Node Biopsy in Early Cervical Cancer

Active, not recruiting
N/A
989
Europe, Canada, Japan, RoW
SLN biopsy only, SLN biopsy + PLN dissection
Centre Hospitalier Universitaire de Besancon, ARCAGY/ GINECO GROUP, European Network of Gynaecological Oncological Trial Groups (ENGOT)
Cervical Cancer
05/27
05/29
Kubala, Otakar
NCT05161507: Magseed and Magtrace Localization for Breast Cancer

Completed
N/A
70
RoW
Magseed, Magtrace, Axillary lymph node metastasis - needle biopsy
University Hospital Ostrava
Breast Carcinoma, Breast Carcinoma Metastatic in Lymph Node
12/21
12/23
IMTAD, NCT04580251: Ideal Marker for Targeted Axillary Dissection

Completed
N/A
100
RoW
Targeted axillary dissection
University Hospital Ostrava, Silesian Hospital in Opava, Masaryk Memorial Cancer Institute, EUC Clinic in Zlín, Institute for the Care of Mother and Child, Prague, Czech Republic, University of Ostrava
Breast Cancer
01/23
05/23
Prokop, Jiří
NCT05161507: Magseed and Magtrace Localization for Breast Cancer

Completed
N/A
70
RoW
Magseed, Magtrace, Axillary lymph node metastasis - needle biopsy
University Hospital Ostrava
Breast Carcinoma, Breast Carcinoma Metastatic in Lymph Node
12/21
12/23
Vávra, Petr
NCT05161507: Magseed and Magtrace Localization for Breast Cancer

Completed
N/A
70
RoW
Magseed, Magtrace, Axillary lymph node metastasis - needle biopsy
University Hospital Ostrava
Breast Carcinoma, Breast Carcinoma Metastatic in Lymph Node
12/21
12/23
NCT03986736: Markers of Tissue Injury and Rhabdomyolysis in Patients With Major Trauma

Completed
N/A
150
RoW
Laboratory analysis - upon admission, Laboratory analysis - 24 hours after injury
University Hospital Ostrava
Tissue Injury, Major Trauma, Rhabdomyolysis
12/22
12/22
IMTAD, NCT04580251: Ideal Marker for Targeted Axillary Dissection

Completed
N/A
100
RoW
Targeted axillary dissection
University Hospital Ostrava, Silesian Hospital in Opava, Masaryk Memorial Cancer Institute, EUC Clinic in Zlín, Institute for the Care of Mother and Child, Prague, Czech Republic, University of Ostrava
Breast Cancer
01/23
05/23
NCT04444479: Insertion of PICC With Intracavitary ECG Navigation

Completed
N/A
450
RoW
ECG verification, X-ray verification
University Hospital Ostrava
Long-term Venous Access
01/23
04/23
NCT04466579: Influence of Monitoring the Depth of General Anesthesia Upon the Incidence of PONV and Emergence Delirium in Children Undergoing Endoscopic Adenoidectomy in General Anesthesia

Completed
N/A
100
RoW
BIS monitor, Standard care
University Hospital Ostrava
Postoperative Nausea, Postoperative Vomiting, Emergence Delirium
05/23
06/23
Cvek, Jakub
EMBER-4, NCT05514054: A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer

Recruiting
3
6000
Europe, Canada, Japan, US, RoW
Imlunestrant, LY3484356, Tamoxifen, Anastrozole, Letrozole, Exemestane
Eli Lilly and Company
Breast Neoplasms
10/27
03/32
NCT04612140: STereotactic Ablative Radiosurgery of Recurrent Ventricular Tachycardia in Structural Heart Disease

Recruiting
N/A
100
RoW
Radiosurgery, Repeated catheter ablation
University Hospital Ostrava, Institute for Clinical and Experimental Medicine, Hospital Podlesi
Ventricular Tachycardia
12/25
12/25
NCT05647590: SBRT/RT in Oligometastatic Stage IV NSCLC

Recruiting
N/A
10
RoW
Chemotherapy, Radiotherapy (RT) + Stereotactic Body Ratio Therapy (SBRT), Maintenance chemotherapy
University Hospital Ostrava
Non Small Cell Lung Cancer
12/24
12/25
RELIEF-AP, NCT05600751: Radiosurgery of Ganglion StELlatum In Patients With REFractory Angina Pectoris

Recruiting
N/A
10
RoW
Radiosurgery of ganglion stellatum
University Hospital Ostrava, Nemocnice AGEL Trinec-Podlesi a.s.
Coronary Artery Disease, Angina Pectoris, Myocardial Ischemia
12/24
12/24
FARHEAD, NCT05348486: FMISO-based Adaptive Radiotherapy for Head and Neck Cancer

Recruiting
N/A
120
RoW
Dose escalation
University Hospital Olomouc, Masaryk Memorial Cancer Institute, University Hospital Ostrava
Head and Neck Cancer, Hypoxia, FMISO, Dose Escalation
06/25
06/30
Pleva, Leoš
NCT04859985: The SELUTION DeNovo Study

Active, not recruiting
N/A
3326
Europe, RoW
SELUTION SLR, DES
M.A. Med Alliance S.A.
Coronary Artery Disease
08/25
07/30
Resova, Kamila
HLX10-020-SCLC302, NCT05353257 / 2022-002226-27: A Study to Evaluate the Efficacy and Safety of Serplulimab in Combination With Chemotherapy and Concurrent Radiotherapy in Patients With Limited-Stage Small Cell Lung Cancer

Active, not recruiting
3
511
Europe, US, RoW
HLX10, Serplulimab, carboplatin/cisplatin-etoposide, Thoracic radiotherapy, Placebo, Prophylactic Cranial Irradiation (PCI)
Shanghai Henlius Biotech, Shanghai Henlius Biotech, Inc.
Limited-Stage Small Cell Lung Cancer
07/25
12/26
Evin, Lukáš
NCT05726695: The Use of Blood Biochemical Markers for Diagnostics of Heart Muscle Diseases

Active, not recruiting
N/A
200
RoW
microRNA test, Heart ultrasound examination
University Hospital Ostrava
Heart Failure, Heart Dilation, Left Ventricular Hypertrophy
12/22
12/23

Download Options